The modification of proteins with ubiquitin is an important cellular mechanism for targeting abnormal or short-lived proteins for degradation. Ubiquitination involves at least three classes of enzymes: ubiquitin-activating enzymes, or E1s, ubiquitin-conjugating enzymes, or E2s, and ubiquitin-protein ligases, or E3s. This gene encodes a member of the E2 ubiquitin-conjugating enzyme family. This enzyme functions in the ubiquitination of the tumor-suppressor protein p53, which is induced by an E3 ubiquitin-protein ligase. Two alternatively spliced transcript variants have been found for this gene and they encode distinct isoforms. [provided by RefSeq, Jul 2008].
Peters, Rees, Hardwick, Hardwick, Vowler, Ong, Zhang, Save, ODonovan, Rassl, Alderson, Caldas, Fitzgerald: "A 4-gene signature predicts survival of patients with resected adenocarcinoma of the esophagus, junction, and gastric cardia." in: Gastroenterology, Vol. 139, Issue 6, pp. 1995-2004.e15, (2010) (PubMed).
Desforges, Lacey, Glazier, Greenwood, Mynett, Speake, Sibley: "SNAT4 isoform of system A amino acid transporter is expressed in human placenta." in: American journal of physiology. Cell physiology, Vol. 290, Issue 1, pp. C305-12, (2005) (PubMed).